
BLPH
Healthcare · Biotechnology · $146,792 market cap
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2023
EPS trend, 90 days to now · 30-day revisions 1 up, 1 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 14, 2023 | After the close | -0.44 | -0.16 | +63.6% |
| Aug 14, 2023 | After the close | -0.42 | -0.42 | 0.0% |
| May 15, 2023 | After the close | -0.49 | 0.27 | +155.1% |
| Mar 31, 2023 | Before the open | -0.48 | -0.53 | -10.4% |
| Nov 14, 2022 | Before the open | -0.58 | -0.53 | +8.6% |
| Aug 15, 2022 | Before the open | -0.60 | -0.43 | +28.3% |
| May 11, 2022 | Before the open | -0.55 | -0.59 | -7.3% |
| Mar 31, 2022 | After the close | -0.60 | -0.45 | +25.0% |
| Nov 15, 2021 | Before the open | -0.63 | -0.49 | +22.2% |
| Aug 5, 2021 | Before the open | -0.66 | -0.36 | +45.5% |
| May 11, 2021 | Before the open | -0.71 | -0.58 | +18.3% |
| Mar 11, 2021 | Before the open | -0.90 | -0.86 | +4.4% |
| Nov 5, 2020 | Before the open | -0.83 | -0.84 |
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its primary product is INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse, which is in Phase 3 clinical trial for the treatment of…
| -1.2% |
| Aug 5, 2020 | Before the open | -0.72 | -0.51 | +29.2% |
| Apr 6, 2020 | Before the open | -1.05 | -1.00 | +4.8% |
| Nov 6, 2019 | Before the open | -1.10 | -0.90 | +18.2% |
| Aug 8, 2019 | Before the open | -1.05 | -0.90 | +14.3% |
| May 9, 2019 | Before the open | -0.10 | -0.15 | -50.0% |
| Mar 14, 2019 | Before the open | -1.95 | -1.05 | +46.2% |
| Nov 7, 2018 | Before the open | -1.80 | -1.50 | +16.7% |
| Aug 1, 2018 | Before the open | -1.50 | -3.00 | -100.0% |
| May 10, 2018 | Before the open | -2.10 | 1.05 | +150.0% |
| Mar 15, 2018 | After the close | -0.22 | -2.00 | -809.1% |